Levodopa Carbidopa Intestinal Gel in Advanced Parkinson’s Disease: DUOGLOBE Final 3-Year Results

BACKGROUND: Levodopa-carbidopa intestinal gel (LCIG) improves motor and non-motor symptoms in patients with advanced Parkinson’s disease (aPD). OBJECTIVE: To present the final 36-month efficacy and safety results from DUOGLOBE (DUOdopa/Duopa in Patients with Advanced Parkinson’s Disease – a GLobal O...

Descripción completa

Detalles Bibliográficos
Autores principales: Chaudhuri, K. Ray, Kovács, Norbert, Pontieri, Francesco E., Aldred, Jason, Bourgeois, Paul, Davis, Thomas L., Cubo, Esther, Anca-Herschkovitsch, Marieta, Iansek, Robert, Siddiqui, Mustafa S., Simu, Mihaela, Bergmann, Lars, Ballina, Mayra, Kukreja, Pavnit, Ladhani, Omar, Jia, Jia, Standaert, David G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2023
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473130/
https://www.ncbi.nlm.nih.gov/pubmed/37302039
http://dx.doi.org/10.3233/JPD-225105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473130/
https://www.ncbi.nlm.nih.gov/pubmed/37302039
http://dx.doi.org/10.3233/JPD-225105

Ejemplares similares